Read More

Ainos Issues Mid-Year Business Update Letter to Shareholders; Ramping Up Marketing Of VELDONA Pet And Aiming To Complete Clinical Trials In Taiwan Of Its Flagship AI Nose-Powered POCT By The End Of 2023

Company ramping up marketing of VELDONA® Pet and aiming to complete clinical trials in Taiwan of its flagship AI Nose-powered POCT by the end of 2023 Ainos sees VELDONA® Pet and AI Nose-powered POCT as key

AIMD